Associated Papers
Surfactant Protein (SP)-A Benefits Over SP-A Mutant: A Preliminary Study for Interstitial Lung Disease Treatment.
Desroziers T et al.
American Journal of Respiratory Cell and Molecular Biology, 2025
Penetrance of interstitial lung disease and lung cancer in carriers of SFTPA1 or SFTPA2 pathogenic variants.
Ducrot L et al.
Erj Open Research, 2025
Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer.
Legendre M et al.
The European Respiratory Journal, 2020
Select a paper to view details